Literature DB >> 4155762

Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.

C G Regårdh, K O Borg, R Johansson, G Johnsson, L Palmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4155762     DOI： 10.1007/bf01061407

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  10 in total

1.  Direct proportionality of urinary excretion rate and serum level of tetracycline in human subjects.

Authors:  T CHULSKI; R H JOHNSON; C A SCHLAGEL; J G WAGNER
Journal:  Nature       Date:  1963-05-04       Impact factor: 49.962

2.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

3.  The disposition of propranolol. I. Elimination during oral absorption in man.

Authors:  D G Shand; R E Rangno
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

4.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

5.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

6.  Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1970-01       Impact factor: 3.534

7.  Pharmacokinetic model for chlordiazepoxide--HCl in the dog.

Authors:  S A Kaplan; M Lewis; M A Schwartz; E Postma; S Cotler; C W Abruzzo; T L Lee; R E Weinfeld
Journal:  J Pharm Sci       Date:  1970-11       Impact factor: 3.534

8.  Influence of first-pass effect on availability of drugs on oral administration.

Authors:  M Gibaldi; R N Boyes; S Feldman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

9.  Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.

Authors:  B Ablad; E Carlsson; L Ek
Journal:  Life Sci I       Date:  1973-02-01

10.  Prediction of systemic availability from plasma-level data after oral drug administration.

Authors:  D Perrier; M Gibaldi; R N Boyes
Journal:  J Pharm Pharmacol       Date:  1973-03       Impact factor: 3.765
  10 in total
  64 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Bioavailability of beta-adrenoceptor blocking drugs.

Authors:  G Johnsson; C G Regardh
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

Review 3.  Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.

Authors:  Y Yamada; K Matsuyama; K Ito; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

4.  Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.

Authors:  Swati Nagar; Richard C Korzekwa; Ken Korzekwa
Journal:  Mol Pharm       Date:  2017-07-31       Impact factor: 4.939

Review 5.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

6.  Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.

Authors:  Tuba Incecayir; Yasuhiro Tsume; Gordon L Amidon
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

7.  A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.

Authors:  J W Rigby; A K Scott; G M Hawksworth; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

8.  Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations.

Authors:  Ina Gesquiere; Adam S Darwich; Bart Van der Schueren; Jan de Hoon; Matthias Lannoo; Christophe Matthys; Amin Rostami; Veerle Foulon; Patrick Augustijns
Journal:  Br J Clin Pharmacol       Date:  2015-07-06       Impact factor: 4.335

9.  Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.

Authors:  A Sandberg; I Blomqvist; U E Jonsson; P Lundborg
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.

Authors:  B Oosterhuis; J H Jonkman; F A Kerkhof
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.